Most Read Articles
Roshini Claire Anthony, 16 Oct 2019

Antibiotic prophylaxis with azithromycin in individuals with primary antibody deficiencies (PAD) may lead to a reduced risk of respiratory exacerbations, according to a phase II trial presented at ERS 2019.

Is once-daily dosing the practical choice for asthma maintenance?

04 Aug 2017

Once-daily dosing with Relvar® Ellipta® provides better symptom control and reduced disease exacerbations in asthma. Dr Celeste Mae L. Campomanes emphasized that with better asthma control, patients would not lose days off from work or school. Moreover, they will be able to control their symptoms without having more exacerbations, which could lead to hospitalization and increased use of antibiotics unnecessarily.

Look out for the Symposium Highlight article on to find out more about the use of 
Relvar® Ellipta®.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 16 Oct 2019

Antibiotic prophylaxis with azithromycin in individuals with primary antibody deficiencies (PAD) may lead to a reduced risk of respiratory exacerbations, according to a phase II trial presented at ERS 2019.